Adaptive Biotechnologies shareholders elect Chad Robins and approve say-on-pay, auditor

Adaptive Biotechnologies Corp

Chad Robins elected Class III director with 80.95% of votes cast; 12.8M broker non-votes.
Say-on-pay advisory proposal passed with 98.46% support; 1.23% against.
Ratification of Ernst & Young as 2025 auditor approved with 99.91% of votes.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.